The GCC Innovative Drug Discovery and Development (IDDD) Consortium would like to invite you to REGISTER to virtually audit our 3rd Annual Foundations of Cancer Therapeutics Course that will take place from 10 am – 3 pm August 14-18.  This year’s 1-week course will focus on therapeutic development from early discovery through clinical trials.  Note that while cancer therapeutics will be highlighted, the majority of what we will cover is disease-agnostic, so all with research in drug development are invited to join.  

Confirmed speakers include Zhiqiang An, Univ. of Texas Health Science Center; Roderick Dashwood, Texas A&M Institute of Biosciences and Technology; Peter Davies, Texas A&M Institute of Biosciences and Technology;  Ahsan Farooqi, MD Anderson Cancer Center; Sarah Hein, March Biosciences; Philip Jones, MDA; Qingyun (Jim) Liu, Univ. of Texas Health Science Center;  Wenshe Liu, Texas A&M Univ.; Cliona Rooney, Baylor College of Medicine/Texas Children’s Hospital; Suzanne Tomlinson, Gulf Coast Consortia.

Related Events

• 

  Save the date: 5th Annual Gulf Coast Consortia Innovative Drug Discovery and Development Conference,

  May 7 – May 8